
- The San Francisco Chronicle's primer on the JP Morgan health care conference.
- Bad Science has some thoughts on the as-yet-released ENHANCE trial of Zetia, which we wrote about here.
- Reuters reports that Sanofi-aventis is looking for growth in the vaccines market.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.